Phillips; M. Ian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Phillips; M. Ian.The latest application filed is for "stem cell beacon".

Company Profile

0.6.9

Phillips; M. Ian - Tampa FL
Phillips; M. Ian - Claremont CA
Phillips; M. Ian - Gainesville FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vigilant cells Grant 9,040,676 - Phillips , et al. May 26, 2	2015-05-26
Stem cell beacon Grant 8,569,471 - Phillips , et al. October 29, 2	2013-10-29
Stem Cell Beacon App 20120164212 - Phillips; M. Ian ; et al.	2012-06-28
Stem Cell Beacon App 20070238675 - Phillips; M. Ian ; et al.	2007-10-11
Vigilant cells App 20070117766 - Phillips; M. Ian ; et al.	2007-05-24
Article Of Manufacture Comprising Aromatic Amino Acids Isomers, Analogs, Or Derivatives Thereof To Treat Neurological Disorders Involving Dysfunction Of Glutamatergic Synaptic Transmission App 20070088074 - Martynyuk; Anatoly E. ; et al.	2007-04-19
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors App 20040266851 - Martynyuk, Anatoly E. ; et al.	2004-12-30
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors App 20040147590 - Martynyuk, Anatoly E. ; et al.	2004-07-29
Antisense nucleic acids App 20030220287 - Phillips, M. Ian ; et al.	2003-11-27
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors App 20030216472 - Martynyuk, Anatoly E. ; et al.	2003-11-20
Antisense compositions targeted to beta1-adrenoceptor-specific mRNA and methods of use App 20030191080 - Phillips, M. Ian ; et al.	2003-10-09
Antisense compositions targeted to .beta.1-adrenoceptor-specific mRNA and methods of use Grant 6,489,307 - Phillips , et al. December 3, 2	2002-12-03
Antisense oligonucleotide compositions targeted to angiotensin converting enzyme MRNA and methods of use Grant 6,248,724 - Moore , et al. June 19, 2	2001-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.